The Institute of Cancer research is one of the world’s most influential cancer research organisations who work in a unique partnership with The Royal Marsden hospital.

The incidence of thyroid cancer is growing and whilst most are thankfully cured, 10-30% of patients suffer potentially life-threatening relapses.

For these patients, there are few options and so there is an urgent need to find new treatments, We spoke about how the £5,000 grant that was awarded by ACT is supporting research into the use of immunotherapy in the treatment of thyroid cancer.

It was exciting to hear about their ambitious aim for side-effect free effective treatment and to hear how close they are to clinical trials with patients.